163 related articles for article (PubMed ID: 26130675)
1. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
[TBL] [Abstract][Full Text] [Related]
2. Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer.
Tibau A; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2013 Oct; 141(3):485-93. PubMed ID: 24072269
[TBL] [Abstract][Full Text] [Related]
3. Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.
Orucevic A; Chen J; McLoughlin JM; Heidel RE; Panella T; Bell J
Breast J; 2015; 21(2):147-54. PubMed ID: 25600504
[TBL] [Abstract][Full Text] [Related]
4. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
5. Serum inflammatory markers and colorectal cancer risk and survival.
Ghuman S; Van Hemelrijck M; Garmo H; Holmberg L; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Br J Cancer; 2017 May; 116(10):1358-1365. PubMed ID: 28376082
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
[TBL] [Abstract][Full Text] [Related]
9. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Allin KH; Nordestgaard BG; Flyger H; Bojesen SE
Breast Cancer Res; 2011 Jun; 13(3):R55. PubMed ID: 21639875
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
11. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
[No Abstract] [Full Text] [Related]
12. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
[TBL] [Abstract][Full Text] [Related]
13. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
[TBL] [Abstract][Full Text] [Related]
14. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
16. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
[TBL] [Abstract][Full Text] [Related]
17. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
[TBL] [Abstract][Full Text] [Related]
18. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
20. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
